5 Einträge gefunden

1. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer:AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

   1. Pfisterer, Jacobus
   2. Joly, Florence
   3. Kristensen, Gunnar
   4. Rau, Joern
   5. Mahner, Sven
   6. Pautier, Patricia
   7. El-Balat, Ahmed

   2023 - Forschungsinformationssystem des UKE
2. Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)

   1. Emons, Günter
   2. Kurzeder, Christian
   3. Schmalfeldt, Barbara
   4. Neuser, Petra
   5. de Gregorio, Nikolaus
   6. Pfisterer, Jacobus
   7. Park-Simon, Tjoung-Won

   2016 - Forschungsinformationssystem des UKE
3. Towards individualised treatment in ovarian cancer

   1. Mahner, Sven
   2. Pfisterer, Jacobus

   2013 - Forschungsinformationssystem des UKE
4. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.

   1. Harter, Philipp
   2. Hilpert, Felix
   3. Mahner, Sven
   4. Heitz, Florian
   5. Pfisterer, Jacobus
   6. Andreas, Du Bois

   2010 - Forschungsinformationssystem des UKE
5. Prognostic factors for complete debulking in first- and second-line ovarian cancer.

   1. Harter, Philipp
   2. Hilpert, Felix
   3. Mahner, Sven
   4. Kommoss, Stefan
   5. Heitz, Florian
   6. Pfisterer, Jacobus
   7. Andreas, Du Bois

   2009 - Forschungsinformationssystem des UKE